Literature DB >> 15581798

Effects of 3-thia fatty acids on feed intake, growth, tissue fatty acid composition, beta-oxidation and Na+,K+-ATPase activity in Atlantic salmon.

Corina Moya-Falcón1, Erlend Hvattum, Endre Dyrøy, Jon Skorve, Sigurd O Stefansson, Magny S Thomassen, Jan V Jakobsen, Rolf K Berge, Bente Ruyter.   

Abstract

Atlantic salmon (Salmo salar) with an initial mass of 86 g were reared in 12 degrees C seawater for 8 weeks to a final average mass of 250 g. The fish were fed fish meal and fish oil-based diet supplemented with either 0%, 0.3% or 0.6% of tetradecylthioacetic acid (TTA), a 3-thia fatty acid. The specific growth rate (SGR) decreased with increasing dietary dose of TTA. The SGR of the group fed 0% of TTA (Control) was 1.8; that of the group fed 0.3% of TTA (TTA-L) was 1.7, and that of the group fed 0.6% of TTA (TTA-H) was 1.5. The mortality increased with increased dietary dose of TTA. The mitochondrial beta-oxidation capacity in the liver of fish fed the TTA diets was 1.5 to 2 times higher than that of the Control fish. TTA supplementation caused substantial changes in the fatty acid compositions of the phospholipids (PL), triacylglycerols (TAG) and free fatty acids (FFA) of gills, heart and liver. The percentages of n-3 fatty acids, particularly 22:6 n-3, increased in fish fed diets containing TTA, while the percentage of the saturated FAs 14:0 and 16:0 in the PL fractions of the gills and heart decreased. The sum of monounsaturated FAs in the PL and TAG fractions from liver was significantly higher in fish fed diets containing TTA. TTA itself was primarily incorporated into PL. Two catabolic products of TTA (sulphoxides of TTA) were identified, and these products were particularly abundant in the kidney. TTA supplementation had no significant effect on the activity of the membrane-bound enzyme Na(+),K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581798     DOI: 10.1016/j.cbpc.2004.08.009

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  7 in total

1.  Mitochondrial activity, hemocyte parameters and lipid composition modulation by dietary conditioning in the Pacific oyster Crassostrea gigas.

Authors:  Tony Dudognon; Christophe Lambert; Claudie Quere; Michel Auffret; Philippe Soudant; Edouard Kraffe
Journal:  J Comp Physiol B       Date:  2014-01-18       Impact factor: 2.200

2.  Effects of dietary supplementation of rapeseed oil on metabolism of [1-14C]18:1n-9, [1-14C]20:3n-6, and [1-14C]20:4n-3 in Atlantic salmon hepatocytes.

Authors:  C Moya-Falcón; M S Thomassen; J V Jakobsen; B Ruyter
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

3.  Effects of tetradecylthioacetic acid (TTA) treatment on lipid metabolism in salmon hearts-in vitro and in vivo studies.

Authors:  Regin Arge; Jens-Erik Dessen; Tone-Kari Østbye; Bente Ruyter; Magny S Thomassen; Kjell-Arne Rørvik
Journal:  Fish Physiol Biochem       Date:  2018-01-19       Impact factor: 2.794

4.  Sesamin modulates gene expression without corresponding effects on fatty acids in Atlantic salmon (Salmo salar L.).

Authors:  A Schiller Vestergren; L Wagner; J Pickova; G Rosenlund; A Kamal-Eldin; S Trattner
Journal:  Lipids       Date:  2012-07-13       Impact factor: 1.880

5.  Anti-inflammatory effects of tetradecylthioacetic acid (TTA) in macrophage-like cells from Atlantic salmon (Salmo salar L.).

Authors:  Fabian Grammes; Harald Takle
Journal:  BMC Immunol       Date:  2011-07-20       Impact factor: 3.615

6.  Regulation of the Omega-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes.

Authors:  Marte Avranden Kjær; Bente Ruyter; Gerd Marit Berge; Yajing Sun; Tone-Kari Knutsdatter Østbye
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

7.  Genome wide response to dietary tetradecylthioacetic acid supplementation in the heart of Atlantic Salmon (Salmo salar L).

Authors:  Fabian Grammes; Kjell-Arne Rørvik; Magny S Thomassen; Rolf K Berge; Harald Takle
Journal:  BMC Genomics       Date:  2012-05-11       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.